Evidence map›Paper›PMID 18551171›Full record

ArticlePLoS pathogens2008

A sporozoite asparagine-rich protein controls initiation of Plasmodium liver stage development.

Olivier Silvie, Kristin Goetz, Kai Matuschewski

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. TwoResearch square · 2025
    Article
  5. Article
  6. Malaria: past, present, and future.Signal transduction and targeted therapy · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. iScience · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Pleiotropic Roles for theFrontiers in cellular and infection microbiology · 2021
    Article
  17. Article
  18. Preparing for Transmission: Gene Regulation inFrontiers in cellular and infection microbiology · 2020
    Review
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Olivier SilvieDepartment of Parasitology, Heidelberg University School of Medicine, Heidelberg, Germany. Olivier.Silvie@med.uni-heidelberg.de
Kristin Goetz
Kai Matuschewski
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmodium sporozoites invade host hepatocytes and develop as liver stages (LS) before the onset of erythrocytic infection and malaria symptoms. LS are clinically silent, and constitute ideal targets for causal prophylactic drugs and vaccines. The molecular and cellular mechanisms underlying LS development remain poorly characterized. Here we describe a conserved Plasmodium asparagine-rich protein that is specifically expressed in sporozoites and liver stages. Gene disruption in Plasmodium berghei results in complete loss of sporozoite infectivity to rodents, due to early developmental arrest after invasion of hepatocytes. Mutant sporozoites productively invade host cells by forming a parasitophorous vacuole (PV), but subsequent remodelling of the membrane of the PV (PVM) is impaired as a consequence of dramatic down-regulation of genes encoding PVM-resident proteins. These early arrested mutants confer only limited protective immunity in immunized animals. Our results demonstrate the role of an asparagine-rich protein as a key regulator of Plasmodium sporozoite gene expression and LS development, and suggest a requirement of partial LS maturation to induce optimal protective immune responses against malaria pre-erythrocytic stages. These findings have important implications for the development of genetically attenuated parasites as a vaccine approach.

Indexed as

AsparagineAnimalsBase SequenceGene Expression RegulationImmunityLiverMiceMolecular Sequence DataMutant ProteinsPlasmodium bergheiProtozoan ProteinsSporozoitesVaccinesAsparagineMutant ProteinsProtozoan ProteinsSLARP protein, PlasmodiumVaccines

Identifiers

PMID18551171
PMCPMC2398788
OpenAlexW2072269419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.